Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03836352
Brief Title: Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

First Submitted : February 7, 2019
First Submitted that Met QC Criteria : February 7, 2019
First Posted : February 11, 2019

Last Update Submitted that Met QC Criteria : June 25, 2021
Last Update Posted : June 28, 2021